Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aspira Women's Health Inc.VRML · Entity 7871 | Director | April 13, 2018 | April 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aspira Women's Health Inc.
Report date April 13, 2018 · Filed April 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 282,296 |
Reported balance
After 2018-04-13 transaction · row 1
1 source rowRow 1 · 2018-04-13 · Grant · Acquired 70,000 · Balance 282,296 F1: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2018 Filed Apr 17, 2018 20:18 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 70,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001488364-18-000001 · primary_doc.xml · nonDerivative · entry 1 Severinghaus Carl · CIK 0001488364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 282,296 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2018, 25% of the restricted stock units will vest on September 1, 2018 and 25% of the restricted stock units will vest on December 1, 2018. Read SEC document |
| March 23, 2017 Filed Mar 27, 2017 20:47 UTC | Aspira Women's Health Inc. VRML · Entity 7871 | GrantCommon Stock | 21,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001488364-17-000001 · primary_doc.xml · nonDerivative · entry 1 Severinghaus Carl · CIK 0001488364 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,296 F1 · shares: The shares of common stock represent restricted stock units with contingent right to receive one share of common stock of Vermillion, Inc. for each restricted stock unit. 50% of the restricted stock units will vest on June 1, 2017, 25% of the restricted stock units will vest on September 1, 2017 and 25% of the restricted stock units will vest on December 1, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.